Evidence map

TrialRadiation oncology (London, England)2024

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Fiorella Di Pastena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39511611